Paper32110403
Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).
Ciftciler R and 3 others. SAGE Open Med, 2020. Cited by 9 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper). Papers, record 32110403. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32110403
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20,863,156 | A new hemostatic agent--Ankaferd blood stopper: management of gastrointestinal bleeding in an infant and other experiences in children. | Pediatr Hematol Oncol | 2010 | https://conductscience.org/library/papers/20863156 | PubMed |
| 2 | 20,677,211 | Upper gastrointestinal bleeding in a patient with defective hemostasis successfully treated with ankaferd blood stopper. | Phytother Res | 2011 | https://conductscience.org/library/papers/20677211 | PubMed |
| 3 | 25,512,727 | Correlation between International Normalized Ratio values and sufficiency of two different local hemostatic measures in anticoagulated patients. | Eur J Dent | 2014 | https://conductscience.org/library/papers/25512727 | PubMed |
| 4 | 21,169,147 | A new practical alternative for the control of sternal bleeding during cardiac surgery: Ankaferd Blood Stopper. | Heart Surg Forum | 2010 | https://conductscience.org/library/papers/21169147 | PubMed |
| 5 | 22,079,213 | Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat. | Crit Rev Oncol Hematol | 2012 | https://conductscience.org/library/papers/22079213 | PubMed |
| 6 | 20,440,107 | The use of Ankaferd blood stopper in a patient with Glanzmann's thrombasthenia with gingival bleeding. | Blood Coagul Fibrinolysis | 2010 | https://conductscience.org/library/papers/20440107 | PubMed |
| 7 | 20,223,504 | Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in a life-threatening renal trauma model. | Urology | 2010 | https://conductscience.org/library/papers/20223504 | PubMed |
| 8 | 19,055,332 | Successful management of bleeding due to solitary rectal ulcer via topical application of Ankaferd blood stopper. | J Altern Complement Med | 2008 | https://conductscience.org/library/papers/19055332 | PubMed |
| 9 | 26,115,159 | Ankaferd blood stopper decreases postoperative bleeding and number of transfusions in patients treated with clopidogrel: a double-blind, placebo-controlled, randomized clinical trial. | Heart Surg Forum | 2015 | https://conductscience.org/library/papers/26115159 | PubMed |
| 10 | 29,198,926 | Does the application of Ankaferd Blood Stopper rectally have positive effects on the healing of colorectal anastomosis and prevention of anastomotic leakage? An experimental study. | Biomed Pharmacother | 2017 | https://conductscience.org/library/papers/29198926 | PubMed |
| 11 | 30,040,068 | On Being a “Physician Patient” with His Own Experimental Therapeutic Drug | Turk J Haematol | 2018 | https://conductscience.org/library/papers/30040068 | PubMed |
| 12 | 30,761,849 | Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance | Turk J Med Sci | 2019 | https://conductscience.org/library/papers/30761849 | PubMed |
| 13 | 22,327,821 | Prohemostatic and antithrombin activities of Ankaferd hemostat are linked to fibrinogen gamma chain and prothrombin by functional proteomic analyses. | Clin Appl Thromb Hemost | 2012 | https://conductscience.org/library/papers/22327821 | PubMed |
| 14 | 25,834,652 | Local use of ankaferd blood clotter in emergent beating heart coronary artery bypass grafting. | Open Cardiovasc Med J | 2015 | https://conductscience.org/library/papers/25834652 | PubMed |
| 15 | 19,849,692 | Haemostatic role and histopathological effects of a new haemostatic agent in a rat bladder haemorrhage model: an experimental trial. | BJU Int | 2010 | https://conductscience.org/library/papers/19849692 | PubMed |
| 16 | 19,215,704 | Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. | J Int Med Res | 2009 | https://conductscience.org/library/papers/19215704 | PubMed |
| 17 | 28,293,423 | Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines. | SAGE Open Med | 2017 | https://conductscience.org/library/papers/28293423 | PubMed |
| 18 | 18,304,416 | Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. | J Int Med Res | 2008 | https://conductscience.org/library/papers/18304416 | PubMed |
| 19 | 30,761,848 | Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study | Turk J Med Sci | 2019 | https://conductscience.org/library/papers/30761848 | PubMed |
| 20 | 22,046,083 | Ankaferd hemostat in the management of gastrointestinal hemorrhages. | World J Gastroenterol | 2011 | https://conductscience.org/library/papers/22046083 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,737,120 | Mechanical and Surface Behavior of Contemporary Restorative Materials Exposed to Topical Hemostatic Agents After Artificial Aging: An In Vitro Study. | Polymers (Basel) | 2026 | https://conductscience.org/library/papers/42737120 | PubMed |
| 41,497,042 | Beyond hemostasis: a narrative review on the multifaceted therapeutic potential of Ankaferd Blood Stopper. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/41497042 | PubMed |
| 35,958,818 | Antineoplastic Effects of Ankaferd Hemostat. | Biomed Res Int | 2022 | https://conductscience.org/library/papers/35958818 | PubMed |
| 33,533,829 | Comparison of hemostatic efficacy of topical Ankaferd Blood Stopper on heparinized and nonheparinized rats in bleeding related to liver injury. | Acta Cir Bras | 2021 | https://conductscience.org/library/papers/33533829 | PubMed |
| 32,490,644 | Assessment of Ankaferd Blood Stopper in experimental liver ischemia reperfusion injury | Turk J Med Sci | 2020 | https://conductscience.org/library/papers/32490644 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32110403
GET https://conductscience.org/api/papers/v1/32110403/references?page=2